Match tier Listed
Presence Current · Arkansas
Last published 2020
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Aaron Owen

Researcher

Also affiliated: Regional Health (1990)

Faculty Researcher

6 h-index 7 pubs 295 cited

  • Female
  • Humans
  • Adult
  • Breast Neoplasms
  • Transplantation, Heterologous
  • Transplantation, Heterotopic
  • Tissue Transplantation
  • Aged
  • Antibiotics, Antineoplastic
  • Doxorubicin
  • Middle Aged
  • Adolescent
  • Animals
  • Breast
  • Cell Division

Biography and Research Information

OverviewAI-generated summary

Aaron Owen's research interests include health sciences and medical education. He has contributed to the field through his publications, with his most recent work appearing in 2020. Owen's academic background at the University of Arkansas for Medical Sciences informs his contributions to health sciences research and education.

Metrics

  • h-index: 6
  • Publications: 7
  • Citations: 295

Selected Publications

  • Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model (2020)
    Translational Oncology 26 citations DOI OpenAlex
  • Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene. (2017)
    Journal of Clinical Oncology 2 citations DOI OpenAlex
  • Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients (2017)
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27 citations DOI OpenAlex
  • Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients (2016)
    PLoS ONE 24 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics